Medication for back pain.
Detailed overview.
Last updated Sources checked
How this page was writtenMedication
Based on NHG · WHO · NICE
How do we rate this?
We look at whether the pain decreases and whether people can move and function better again, not at how satisfied patients were with the treatment, because that says little about whether it really works. Independent reviews and bodies such as Cochrane, the WHO, NICE and the Zorginstituut weigh most. When a profession recommends its own treatment, that alone does not earn a high score. Strong comparative research is scarce for back pain, so some ratings are based on limited evidence.
Medication plays a limited role in treating back pain. No medication cures back pain; they can only temporarily relieve symptoms while your body heals. Here is a detailed overview based on WHO (2023), NICE (2016) and recent trials.
NSAIDs
First choiceHow do we rate this?
We look at whether the pain decreases and whether people can move and function better again, not at how satisfied patients were with the treatment, because that says little about whether it really works. Independent reviews and bodies such as Cochrane, the WHO, NICE and the Zorginstituut weigh most. When a profession recommends its own treatment, that alone does not earn a high score. Strong comparative research is scarce for back pain, so some ratings are based on limited evidence.
Of all the painkillers used for back pain, NSAIDs have the best evidence. In a review of 301 placebo-controlled trials they were the only treatment shown to be effective for acute low back pain (Cashin et al., BMJ EBM 2025), and Cochrane (2020) points the same way. Be realistic: the effect is small, and for no painkiller is the evidence really strong (Wewege et al., BMJ 2023).
Examples
Ibuprofen, naproxen, diclofenac
Dosage
Follow the leaflet, and use them for as short a time as possible.
Caution
Take with food. Use caution with stomach issues, kidney disease, heart failure, high blood pressure. Do not combine with blood thinners. Do not use during pregnancy, especially not in the third trimester.
Paracetamol (acetaminophen)
Guidelines disagreeHow do we rate this?
We look at whether the pain decreases and whether people can move and function better again, not at how satisfied patients were with the treatment, because that says little about whether it really works. Independent reviews and bodies such as Cochrane, the WHO, NICE and the Zorginstituut weigh most. When a profession recommends its own treatment, that alone does not earn a high score. Strong comparative research is scarce for back pain, so some ratings are based on limited evidence.
The PACE trial (Williams et al., Lancet 2014) showed that paracetamol is no better than placebo for acute low back pain, and Cochrane (2016) confirmed it. NICE advises against paracetamol on its own; the WHO (2023) guideline on chronic back pain makes no recommendation about it.
Your Dutch GP will probably still suggest it first, and that is not an oversight. The NHG standard for non-specific low back pain names no drugs itself; it refers on to the stepladder in the NHG standard on pain, where paracetamol is step one, on the stated principle of the lightest sufficiently effective treatment with the fewest side effects. The reasoning is different, not the evidence: the standard itself says the effect of painkillers on non-specific back pain is probably limited, and then picks the one that does the least harm. NSAIDs can cause side effects, though. So use them as briefly as possible (NICE).
Why guidelines disagreeOpioids
Not recommendedHow do we rate this?
We look at whether the pain decreases and whether people can move and function better again, not at how satisfied patients were with the treatment, because that says little about whether it really works. Independent reviews and bodies such as Cochrane, the WHO, NICE and the Zorginstituut weigh most. When a profession recommends its own treatment, that alone does not earn a high score. Strong comparative research is scarce for back pain, so some ratings are based on limited evidence.
The OPAL trial (Jones et al., Lancet 2023) showed that opioids are no better than placebo for acute low back pain, but cause more side effects. The WHO (2023) advises against opioids as routine care for chronic back pain, and NICE allows a weak opioid for acute pain only when an NSAID is not possible or does not work. You can also become dependent on opioids.
Muscle relaxants
LimitedHow do we rate this?
We look at whether the pain decreases and whether people can move and function better again, not at how satisfied patients were with the treatment, because that says little about whether it really works. Independent reviews and bodies such as Cochrane, the WHO, NICE and the Zorginstituut weigh most. When a profession recommends its own treatment, that alone does not earn a high score. Strong comparative research is scarce for back pain, so some ratings are based on limited evidence.
Muscle relaxants barely help with back pain. Some give a tiny bit less pain in the first two weeks, but they do not change what you can do, and they can cause side effects (Cashin et al., 2021). The Dutch GP guideline advises against drugs such as diazepam and oxazepam (NHG).
Antidepressants (duloxetine)
Some evidenceHow do we rate this?
We look at whether the pain decreases and whether people can move and function better again, not at how satisfied patients were with the treatment, because that says little about whether it really works. Independent reviews and bodies such as Cochrane, the WHO, NICE and the Zorginstituut weigh most. When a profession recommends its own treatment, that alone does not earn a high score. Strong comparative research is scarce for back pain, so some ratings are based on limited evidence.
Antidepressants have a small effect on chronic back pain compared with placebo (Cashin et al., 2025), and the ACP (2017) names duloxetine as an option. NICE and the WHO (2023) on the other hand advise against antidepressants as routine treatment for back pain; that disagreement is why this scores 3. Only consider for chronic pain, not acute back pain. Must be tapered gradually.
How long do you use painkillers?
Day 1–3
Start if needed
NSAID with food; check with pharmacist or GP if unsure.
After that
Keep it short
As short as possible, and keep moving.
After a month
See your GP
Pain not easing yet? Go to your GP.
Sources
- WHO Guideline on management of chronic primary low back pain (2023)
- Williams CM, et al. Efficacy of paracetamol for acute low back pain. Lancet (2014)
- Jones CMP, et al. Opioid analgesia for acute low back pain. Lancet (2023)
- NICE Guideline NG59 (2016)
- NHG-Standaard Aspecifieke lagerugpijn (2017, laatst gewijzigd 2024)
- NHG-Standaard Pijn (2018), tabel 1: het medicamenteuze stappenplan
- Qaseem A, et al. ACP Clinical Practice Guideline (2017)
- Cashin AG, et al. Muscle relaxants for non-specific low back pain. BMJ (2021)
- Cashin AG, et al. Analgesic effects of non-surgical and non-interventional treatments for low back pain. BMJ Evid Based Med (2025)
- Wewege MA, et al. Comparative effectiveness and safety of analgesic medicines for acute non-specific low back pain. BMJ (2023)
Next step